Growth Metrics

ASP Isotopes (ASPI) Common Equity (2021 - 2025)

ASP Isotopes has reported Common Equity over the past 5 years, most recently at $262.9 million for Q4 2025.

  • For Q4 2025, Common Equity rose 413.8% year-over-year to $262.9 million; the TTM value through Dec 2025 reached $262.9 million, up 413.8%, while the annual FY2025 figure was $262.9 million, 413.8% up from the prior year.
  • Common Equity for Q4 2025 was $262.9 million at ASP Isotopes, up from $96.6 million in the prior quarter.
  • Over five years, Common Equity peaked at $262.9 million in Q4 2025 and troughed at $6.0 million in Q4 2021.
  • A 5-year average of $37.7 million and a median of $13.0 million in 2024 define the central range for Common Equity.
  • Biggest five-year swings in Common Equity: increased 9.36% in 2024 and later soared 413.8% in 2025.
  • Year by year, Common Equity stood at $6.0 million in 2021, then soared by 63.69% to $9.8 million in 2022, then skyrocketed by 91.81% to $18.8 million in 2023, then soared by 171.72% to $51.2 million in 2024, then soared by 413.8% to $262.9 million in 2025.
  • Business Quant data shows Common Equity for ASPI at $262.9 million in Q4 2025, $96.6 million in Q3 2025, and $28.3 million in Q2 2025.